KR101086254B1 - 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 - Google Patents
생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 Download PDFInfo
- Publication number
- KR101086254B1 KR101086254B1 KR1020040089455A KR20040089455A KR101086254B1 KR 101086254 B1 KR101086254 B1 KR 101086254B1 KR 1020040089455 A KR1020040089455 A KR 1020040089455A KR 20040089455 A KR20040089455 A KR 20040089455A KR 101086254 B1 KR101086254 B1 KR 101086254B1
- Authority
- KR
- South Korea
- Prior art keywords
- solid dispersion
- franlukast
- bioavailability
- composition
- preparing
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Abstract
Description
실시예 | 프란루카스트(g) | 고분자(g) | ||
폴리비닐알콜 비닐아세테이트 공중합체 |
폴리비닐피롤리돈 | 폴리비닐알콜 | ||
1 | 6 | 9 | - | - |
2 | 6 | - | 9 | - |
3 | 6 | - | - | 9 |
비교예 | 약 물 | 고 분 자 |
1 | 프란루카스트 6 g | 히드록시프로필셀룰로오스 9g |
2 | 폴리에틸렌글리콜 20000 9g | |
3 | 폴록사머 9g | |
4 | 유드라짓 E 9g | |
5 | 유드라짓 L 9g | |
6 | 유드라짓 S 9g |
실시예 | 약물 | 고분자 (g) | ||
폴리비닐피롤리돈 비닐아세테이트 공중합체 |
폴리비닐피롤리돈 | 폴리비닐알콜 | ||
4 | 1 g | 0.1 | - | - |
5 | 2.0 | - | - | |
6 | 5.0 | - | - | |
7 | 2.0 | 2.0 | - | |
8 | - | 1.0 | - | |
9 | - | 2.5 | - | |
10 | - | 4.0 | - | |
11 | - | 8.0 | - | |
12 | - | 0.5 | 0.5 | |
13 | - | - | 3.0 | |
14 | - | - | 5.0 | |
15 | - | - | 7.0 |
구 분 | 용해도 (㎍/㎖) | |
실시예 | 1 | 114.8 |
2 | 106.1 | |
3 | 105.8 | |
비교예 | 1 | 12.5 |
2 | 0.9 | |
3 | 1.0 | |
4 | 0.2 | |
5 | 0.8 | |
6 | 0.4 |
구 분 | 용해도 (㎍/㎖) | |
실시예 | 4 | 103.5 |
5 | 95.3 | |
6 | 92.8 | |
7 | 111.4 | |
8 | 94.7 | |
9 | 109.6 | |
10 | 113.6 | |
11 | 114.9 | |
12 | 95.7 | |
13 | 113.7 | |
14 | 95.2 | |
15 | 107.4 |
구 분 | 용해도(㎍/㎖) |
프란루카스트 원말 | 0.4 |
실시예 1 | 114.8 |
분무건조체 | 12.5 |
구 분 | 용량 (mg/㎏) | 용해도(㎍/㎖) |
오논 분말 | 20 | 0.4 |
분무 건조체 | 20 | 12.5 |
핫 멜트 고체분산체 | 20 | 114.8 |
구 분 | AUC (ng h/mL) | Cmax (ng/mL) | Tmax (h) | AUC 비 |
오논 분말 | 515.8±200.0 | 196.4±92.6 | 0.63±0.25 | - |
분무 건조체 | 872.2±400.1 | 363.7±162.2 | 0.40±0.14 | 1.7 |
핫 멜트 고체분산체 | 1494.2±385.1 | 884.1±349.9 | 0.56±0.31 | 2.9 |
구 분 | 분체밀도 (g/cm3) |
충진분말량 (mg) |
충진분말부피 (㎖) |
프란루카스트 함량 (mg) |
플라스돈 고체분산체 | 0.56 | 100 | 0.179 | 40 |
포비돈 고체분산체 | 0.54 | 100 | 0.179 | 40 |
폴리비닐알콜 고체분산체 | 0.53 | 100 | 0.179 | 40 |
분무건조체 | 0.11 | 150 | 1.364 | 60 |
오논 분말 | 0.66 | 177 | 0.268 | 112.5 |
구분 | 용출시간 (분) | |||||||
0 | 15 | 30 | 45 | 60 | 90 | 120 | ||
용출률 (%) |
오논 캅셀 | 0.0 | 1.5 | 3.5 | 4.2 | 4.1 | 4.6 | 4.4 |
분무건조체 정제 | 0.0 | 19.1 | 32.2 | 37.6 | 38.7 | 38.0 | 37.6 | |
핫 멜트 캅셀 | 0.0 | 7.9 | 96.6 | 96.4 | 96.4 | 96.2 | 95.6 |
성분명 | 1 cap (mg) | 100 cap (g) |
프란루카스트-폴리비닐피롤리돈비닐아세테이트 공중합체 (프란루카스트 함량) |
250 (100) |
25 (10) |
유당 | 40 | 4 |
크로스포비돈 | 4 | 0.4 |
탈크 | 1 | 0.1 |
합계 | 295 | 29.5 |
Claims (9)
- 프란루카스트에 대한 폴리비닐피롤리돈비닐아세테이트 공중합체가 중량비 0.2 : 1 ~ 10 : 1 로 열에 의해 용융되어 이루어진 것을 특징으로 하는 프란루카스트 고체분산체.
- 프란루카스트와 유리 전이 온도가 100 ∼ 200 ℃인 고분자를 포함하는 것을 특징으로 하는 프란루카스트 고체분산체 조성물.
- 삭제
- 삭제
- 삭제
- 프란루카스트에 대한 폴리비닐피롤리돈비닐아세테이트 공중합체를 중량비 0.2 : 1 ~ 10 : 1 로 혼합하는 단계, 이를 용융 온도 100 ∼ 200 ℃에서 용융시키는 단계 및 용융된 혼합물을 냉각 및 분쇄하여 고체 분산체를 얻는 단계를 특징으로 하는 프란루카스트 고체분산체의 제조방법.
- 삭제
- 삭제
- 삭제
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040089455A KR101086254B1 (ko) | 2004-11-04 | 2004-11-04 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
ARP050104618A AR051758A1 (es) | 2004-11-04 | 2005-11-03 | Composicion de dispersion solida de pranlukast con biodisponibilidad mejorada y metodo para preparar la dispersion solida |
PCT/KR2005/003686 WO2006049433A1 (en) | 2004-11-04 | 2005-11-03 | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion |
MX2007005427A MX2007005427A (es) | 2004-11-04 | 2005-11-03 | Composicion de dispersion solida de pranlukast con biodisponibilidad mejorada y metodo para preparar la dispersion solida. |
JP2007540251A JP5232472B2 (ja) | 2004-11-04 | 2005-11-03 | 向上された生体利用効率を備えるプランルカスト固体分散体組成物およびその固体分散体の製造方法 |
TW094138786A TWI380829B (zh) | 2004-11-04 | 2005-11-04 | 具有改良的生物可利用率之普侖斯特(pranlukast)固態分散物組成物及製備該固態分散物之方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040089455A KR101086254B1 (ko) | 2004-11-04 | 2004-11-04 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060040211A KR20060040211A (ko) | 2006-05-10 |
KR101086254B1 true KR101086254B1 (ko) | 2011-11-24 |
Family
ID=36319405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040089455A KR101086254B1 (ko) | 2004-11-04 | 2004-11-04 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP5232472B2 (ko) |
KR (1) | KR101086254B1 (ko) |
AR (1) | AR051758A1 (ko) |
MX (1) | MX2007005427A (ko) |
TW (1) | TWI380829B (ko) |
WO (1) | WO2006049433A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101446129B1 (ko) * | 2012-10-10 | 2014-10-06 | 조선대학교산학협력단 | 프란루카스트-함유 고형 제제의 제조방법 |
KR20160141620A (ko) | 2015-06-01 | 2016-12-09 | 삼아제약 주식회사 | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101233235B1 (ko) * | 2005-08-26 | 2013-02-15 | 에스케이케미칼주식회사 | 초기 용출율이 개선된 프란루카스트 고체분산체의 약제학적조성물 및 그의 제조방법 |
CN101835492B (zh) | 2007-08-21 | 2012-11-21 | 德克萨斯州立大学董事会 | 用于制药应用的热动力学混合 |
EP4008314A3 (en) * | 2007-08-21 | 2022-11-09 | Board of Regents, The University of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
EP2140861A1 (en) | 2008-06-30 | 2010-01-06 | Abbott GmbH & Co. KG | Pharmaceutical dosage form comprising polymeric carrier composition |
GB201103837D0 (en) * | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
KR101381881B1 (ko) * | 2012-03-12 | 2014-04-04 | 충남대학교산학협력단 | 용해도 및 용출율이 개선된 프란루카스트 나노 고체 분산체의 제조방법 |
KR102191562B1 (ko) * | 2012-11-07 | 2020-12-15 | 에스케이바이오팜 주식회사 | 난용성 약물의 고체분산체 및 이의 제조방법 |
US20210308116A1 (en) | 2018-07-13 | 2021-10-07 | Council Of Scientific And Industrial Research | Solid dispersion comprising an anticancer compound for improved solubility and efficacy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001089574A1 (en) * | 2000-05-20 | 2001-11-29 | Sang Deuk Lee | Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
US20030215496A1 (en) | 1999-11-23 | 2003-11-20 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20040058896A1 (en) | 2000-12-07 | 2004-03-25 | Rango Dietrich | Pharmaceutical preparation comprising an active dispersed on a matrix |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19509807A1 (de) * | 1995-03-21 | 1996-09-26 | Basf Ag | Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen |
US5876760A (en) * | 1995-06-12 | 1999-03-02 | Ono Pharmaceutical Co., Ltd. | Granules containing pranlukast, process for producing the granules, and method of improving adhesiveness of pranlukast |
US5858509A (en) * | 1996-11-15 | 1999-01-12 | Digital Equipment Corporation | Attenuating vibrations in a mounting shelf for multiple disk drives |
-
2004
- 2004-11-04 KR KR1020040089455A patent/KR101086254B1/ko active IP Right Grant
-
2005
- 2005-11-03 WO PCT/KR2005/003686 patent/WO2006049433A1/en active Application Filing
- 2005-11-03 JP JP2007540251A patent/JP5232472B2/ja not_active Expired - Fee Related
- 2005-11-03 AR ARP050104618A patent/AR051758A1/es unknown
- 2005-11-03 MX MX2007005427A patent/MX2007005427A/es not_active Application Discontinuation
- 2005-11-04 TW TW094138786A patent/TWI380829B/zh not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030215496A1 (en) | 1999-11-23 | 2003-11-20 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2001089574A1 (en) * | 2000-05-20 | 2001-11-29 | Sang Deuk Lee | Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
US20040058896A1 (en) | 2000-12-07 | 2004-03-25 | Rango Dietrich | Pharmaceutical preparation comprising an active dispersed on a matrix |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101446129B1 (ko) * | 2012-10-10 | 2014-10-06 | 조선대학교산학협력단 | 프란루카스트-함유 고형 제제의 제조방법 |
KR20160141620A (ko) | 2015-06-01 | 2016-12-09 | 삼아제약 주식회사 | 생체이용률이 개선된 프란루카스트 함유 고형 제제의 조성물 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
TW200621307A (en) | 2006-07-01 |
AR051758A1 (es) | 2007-02-07 |
WO2006049433A1 (en) | 2006-05-11 |
KR20060040211A (ko) | 2006-05-10 |
MX2007005427A (es) | 2012-10-02 |
TWI380829B (zh) | 2013-01-01 |
JP5232472B2 (ja) | 2013-07-10 |
JP2008519067A (ja) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5232472B2 (ja) | 向上された生体利用効率を備えるプランルカスト固体分散体組成物およびその固体分散体の製造方法 | |
KR101159617B1 (ko) | 구강내 속붕해성 정제 | |
KR100479521B1 (ko) | N-피페리디노-3-피라졸카르복사미드 유도체, 그것의 염 및 그것들의 용매화물의 경구 투여용 약제학적 조성물 | |
US6455053B1 (en) | Quickly soluble solid preparations | |
AU2002222567B2 (en) | Composition improved in solubility or oral absorbability | |
JPS62292720A (ja) | 制御放出型ジヒドロコデイン組成物 | |
KR20090042961A (ko) | 고도 결정질 치료용 화합물의 고체 분산체 제조 방법 | |
KR100381834B1 (ko) | 용출성이 개선된 프란루카스트 고체분산체 조성물 및 그제조 방법 | |
EP2886109B1 (en) | Medicament-containing hollow particle | |
CA1146545A (en) | Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin | |
KR100908418B1 (ko) | 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법 | |
KR0172134B1 (ko) | 고형 제제 | |
EP1466914A1 (en) | Amorphous substance of tricyclic triazolobenzazepine derivative | |
WO2013032310A1 (ko) | 메게스트롤 속붕해정 및 이의 제조 방법 | |
JPH11116464A (ja) | 迅速溶解性固形製剤およびその製造法 | |
KR100671714B1 (ko) | 미분화된 펠로디핀 함유 지속 방출성 제제 | |
JP2813792B2 (ja) | マレイン酸イルソグラジン経口投与用製剤およびその製造法 | |
KR20210047319A (ko) | 징코 테르펜 락톤을 유효성분으로 포함하는 드롭필 및 이의 제조 방법 | |
JP5241681B2 (ja) | アムロジピン含有粒子およびそれからなる口腔内崩壊錠 | |
CN101658543A (zh) | 千层塔片及其制造方法 | |
CN101658544A (zh) | 千层塔控释片及其制造方法 | |
CN101623317A (zh) | 千层塔口崩片及其制造方法 | |
CN101785762A (zh) | 石杉碱甲口崩片及其制造方法 | |
KR20080071286A (ko) | 암로디핀 함유 입자 및 그것을 포함하는 구강 내 붕괴정 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20141020 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151020 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20161020 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20171020 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20181101 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20191104 Year of fee payment: 9 |